Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma (DESPARTH)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02304289 |
|
Recruitment Status :
Terminated
(slow recruitment of patients)
First Posted : December 1, 2014
Last Update Posted : October 27, 2021
|
Sponsor:
University Hospital, Ghent
Collaborators:
University Ghent
Anticancer Fund, Belgium
Information provided by (Responsible Party):
University Hospital, Ghent
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | December 2016 |
| Actual Study Completion Date : | December 2016 |